Ana Maria Cuervo

Last updated
Ana Maria Cuervo
Ana Maria Cuervo.jpg
Ana Maria Cuervo in 2008
Born (1966-07-14) July 14, 1966 (age 57)
NationalitySpanish and American
Occupation(s)Scientist, cell biologist
Known for Chaperone-mediated autophagy research
Website Research lab

Ana Maria Cuervo (born 14 July 1966) is a Spanish-American physician, researcher, and cell biologist. She is a professor in developmental and molecular miology, anatomy and structural biology, and medicine and co-director of the Institute for Aging Studies at the Albert Einstein College of Medicine. She is best known for her research work on autophagy, the process by which cells recycle waste products, and its changes in aging and age-related diseases.

Contents

Biography

Cuervo was born in Barcelona, Spain, on 14 July 1966. She studied medicine at the University of Valencia in 1986 and further pursued a PhD in biochemistry and molecular biology under the mentorship of Erwin Knecht, a biochemist studying lysosomes and proteosome at the time. [1] In 1993, she published her first academic paper as a co-author on lysosomal degradation which challenged the assumption that it was non-specific. [2] Cuervo also worked with Fred “Paulo” Dice of Tufts University on lysosomes during the summer months as Spanish labs were closed during this time of year. Cuervo later accepted a full-time post-doctorate position at Dice's laboratory and focused on understanding the lysosomal degradation pathway. In 1996 and 2000, Cuervo and Dice published their findings on this pathway, identified the lysosomal membrane protein LAMP2A as the receptor for this form of autophagy and termed it chaperone-mediated autophagy. [3] [4]

In October 2001, Cuervo accepted a faculty position at the Albert Einstein College of Medicine in The Bronx, New York. She continue primarily focusing on chaperone-mediated autophagy and its role in aging and human disease. Her research lab focused on protein translocations across lysosomal membranes, identifying regulator proteins like glial fibrillary acidic protein. [5] In collaboration with neuroscientist David Sulzer of Columbia University Medical Center, she published evidence of altered chaperone-mediated autophagy in Parkinson's disease. [6] Similar findings of disrupted autophagy was also reported when Huntington Disease was studied. [7] Cuervo's research team also identified LRRK2, a protein enzyme that becomes mutated in Parkinson's disease, disrupts the process of translocation across lysosomal membranes. [8] [1]

She is also co-director of the Einstein Institute for Aging Research and a member of the Einstein Liver Research Center and Cancer Center. She is also the Robert and Renée Belfer Chair for the Study of Neurodegenerative Diseases at Albert Einstein College of Medicine. In 2015 she was elected International Academic of the Royal Academy of Medicine of the Valencia Community and in 2017, member of the Real Academia de Ciencias Exactas, Fisicas y Naturales. In 2018, Cuervo was elected a member of the American Academy of Arts and Sciences. [9]

She has also served as a member of the National Institute on Aging (NIA) Scientific Council, NIH Scientific Council of Councils, NIA Board of Scientific Counselors and in the Advisory Committee to the NIH Deputy Director. [10] Dr. Cuervo is also one of the founding members of the Women in Autophagy (WIA) network dedicate to promote careers of young scientist interested in autophagy.

Cuervo is co-editor-in-chief of the Aging Cell journal and serves in the editorial board of Cell Metabolism and Molecular Cell. [11] She has been involved in more than 200 publications. [12] Dr. Cuervo has been included in the 2018, 2019, 2020 Highly Cited Researchers List (ranking of top 1% cited researchers).

Recognition

Cuervo and her team have received numerous awards including the P. Benson Award, Keith Porter Fellow, Nathan Shock Memorial Award, Vincent Cristofalo Award in Aging, Bennett J. Cohen, Marshall Horwitz Prize and the Saul Korey Prize in Translational Medicine. She has delivered prominent lectures such as the Robert R. Konh, the NIH Director’s, the Roy Walford, the Feodor Lynen, the Margaret Pittman, the IUBMB, the David H. Murdoxk, the Gerry Aurbach and the SEBBM L’Oreal-UNESCO for Women in Science, and the Harvey Lecture. She also received twice the LaDonne Schulman Teaching Award . [13] She was elected to the National Academy of Sciences in 2019. [14]

Personal life

Cuervo speaks Spanish, and English. Cuervo's husband is Dr. Fernando Macian, an immunologist at Albert Einstein College of Medicine. [1]

Related Research Articles

Cell biology is a branch of biology that studies the structure, function, and behavior of cells. All living organisms are made of cells. A cell is the basic unit of life that is responsible for the living and functioning of organisms. Cell biology is the study of the structural and functional units of cells. Cell biology encompasses both prokaryotic and eukaryotic cells and has many subtopics which may include the study of cell metabolism, cell communication, cell cycle, biochemistry, and cell composition. The study of cells is performed using several microscopy techniques, cell culture, and cell fractionation. These have allowed for and are currently being used for discoveries and research pertaining to how cells function, ultimately giving insight into understanding larger organisms. Knowing the components of cells and how cells work is fundamental to all biological sciences while also being essential for research in biomedical fields such as cancer, and other diseases. Research in cell biology is interconnected to other fields such as genetics, molecular genetics, molecular biology, medical microbiology, immunology, and cytochemistry.

<span class="mw-page-title-main">Lysosome</span> Cell organelle

A lysosome is a membrane-bound organelle found in many animal cells. They are spherical vesicles that contain hydrolytic enzymes that can break down many kinds of biomolecules. A lysosome has a specific composition, of both its membrane proteins, and its lumenal proteins. The lumen's pH (~4.5–5.0) is optimal for the enzymes involved in hydrolysis, analogous to the activity of the stomach. Besides degradation of polymers, the lysosome is involved in various cell processes, including secretion, plasma membrane repair, apoptosis, cell signaling, and energy metabolism.

<span class="mw-page-title-main">Lysosomal storage disease</span> Medical condition

Lysosomal storage diseases are a group of over 70 rare inherited metabolic disorders that result from defects in lysosomal function. Lysosomes are sacs of enzymes within cells that digest large molecules and pass the fragments on to other parts of the cell for recycling. This process requires several critical enzymes. If one of these enzymes is defective due to a mutation, the large molecules accumulate within the cell, eventually killing it.

<span class="mw-page-title-main">Autophagy</span> Cellular catabolic process in which cells digest parts of their own cytoplasm

Autophagy is the natural, conserved degradation of the cell that removes unnecessary or dysfunctional components through a lysosome-dependent regulated mechanism. It allows the orderly degradation and recycling of cellular components. Although initially characterized as a primordial degradation pathway induced to protect against starvation, it has become increasingly clear that autophagy also plays a major role in the homeostasis of non-starved cells. Defects in autophagy have been linked to various human diseases, including neurodegeneration and cancer, and interest in modulating autophagy as a potential treatment for these diseases has grown rapidly.

<span class="mw-page-title-main">Heat shock response</span> Type of cellular stress response

The heat shock response (HSR) is a cell stress response that increases the number of molecular chaperones to combat the negative effects on proteins caused by stressors such as increased temperatures, oxidative stress, and heavy metals. In a normal cell, proteostasis must be maintained because proteins are the main functional units of the cell. Many proteins take on a defined configuration in a process known as protein folding in order to perform their biological functions. If these structures are altered, critical processes could be affected, leading to cell damage or death. The heat shock response can be employed under stress to induce the expression of heat shock proteins (HSP), many of which are molecular chaperones, that help prevent or reverse protein misfolding and provide an environment for proper folding.

<span class="mw-page-title-main">HSPA8</span> Protein-coding gene in the species Homo sapiens

Heat shock 70 kDa protein 8 also known as heat shock cognate 71 kDa protein or Hsc70 or Hsp73 is a heat shock protein that in humans is encoded by the HSPA8 gene on chromosome 11. As a member of the heat shock protein 70 family and a chaperone protein, it facilitates the proper folding of newly translated and misfolded proteins, as well as stabilize or degrade mutant proteins. Its functions contribute to biological processes including signal transduction, apoptosis, autophagy, protein homeostasis, and cell growth and differentiation. It has been associated with an extensive number of cancers, neurodegenerative diseases, cell senescence, and aging.

<span class="mw-page-title-main">Bafilomycin</span> Chemical compound

The bafilomycins are a family of macrolide antibiotics produced from a variety of Streptomycetes. Their chemical structure is defined by a 16-membered lactone ring scaffold. Bafilomycins exhibit a wide range of biological activity, including anti-tumor, anti-parasitic, immunosuppressant and anti-fungal activity. The most used bafilomycin is bafilomycin A1, a potent inhibitor of cellular autophagy. Bafilomycins have also been found to act as ionophores, transporting potassium K+ across biological membranes and leading to mitochondrial damage and cell death.

In eukaryotic cells, an aggresome refers to an aggregation of misfolded proteins in the cell, formed when the protein degradation system of the cell is overwhelmed. Aggresome formation is a highly regulated process that possibly serves to organize misfolded proteins into a single location.

Lysosomal lipase is a form of lipase which functions intracellularly, in the lysosomes.

<span class="mw-page-title-main">LAMP2</span> Protein-coding gene in the species Homo sapiens

Lysosome-associated membrane protein 2 (LAMP2), also known as CD107b and Mac-3, is a human gene. Its protein, LAMP2, is one of the lysosome-associated membrane glycoproteins.

<span class="mw-page-title-main">VPS35</span> Protein-coding gene in the species Homo sapiens

Vacuolar protein sorting ortholog 35 (VPS35) is a protein involved in autophagy and is implicated in neurodegenerative diseases, such as Parkinson's disease (PD) and Alzheimer's disease (AD). VPS35 is part of a complex called the retromer, which is responsible for transporting select cargo proteins between vesicular structures and the Golgi apparatus. Mutations in the VPS35 gene (VPS35) cause aberrant autophagy, where cargo proteins fail to be transported and dysfunctional or unnecessary proteins fail to be degraded. There are numerous pathways affected by altered VPS35 levels and activity, which have clinical significance in neurodegeneration. There is therapeutic relevance for VPS35, as interventions aimed at correcting VPS35 function are in speculation.

<span class="mw-page-title-main">TFEB</span> Protein-coding gene in the species Homo sapiens

Transcription factor EB is a protein that in humans is encoded by the TFEB gene.

<span class="mw-page-title-main">LAPTM4B</span> Protein-coding gene in the species Homo sapiens

Lysosomal-associated transmembrane protein 4B is a protein that in humans is encoded by the LAPTM4B gene.

Proteostasis is the dynamic regulation of a balanced, functional proteome. The proteostasis network includes competing and integrated biological pathways within cells that control the biogenesis, folding, trafficking, and degradation of proteins present within and outside the cell. Loss of proteostasis is central to understanding the cause of diseases associated with excessive protein misfolding and degradation leading to loss-of-function phenotypes, as well as aggregation-associated degenerative disorders. Therapeutic restoration of proteostasis may treat or resolve these pathologies. Cellular proteostasis is key to ensuring successful development, healthy aging, resistance to environmental stresses, and to minimize homeostatic perturbations from pathogens such as viruses. Cellular mechanisms for maintaining proteostasis include regulated protein translation, chaperone assisted protein folding, and protein degradation pathways. Adjusting each of these mechanisms based on the need for specific proteins is essential to maintain all cellular functions relying on a correctly folded proteome.

<span class="mw-page-title-main">David Sulzer</span> American neuroscientist and musician

David Sulzer is an American neuroscientist and musician. He is a professor at Columbia University Medical Center in the departments of psychiatry, neurology, and pharmacology. Sulzer's laboratory investigates the interaction between the synapses of the cerebral cortex and the basal ganglia, including the dopamine system, in habit formation, planning, decision making, and diseases of the system. His lab has developed the first means to optically measure neurotransmission, and has introduced new hypotheses of neurodegeneration in Parkinson's disease, and changes in synapses that produce autism and habit learning.

<span class="mw-page-title-main">Chaperone-mediated autophagy</span>

Chaperone-mediated autophagy (CMA) refers to the chaperone-dependent selection of soluble cytosolic proteins that are then targeted to lysosomes and directly translocated across the lysosome membrane for degradation. The unique features of this type of autophagy are the selectivity on the proteins that are degraded by this pathway and the direct shuttling of these proteins across the lysosomal membrane without the requirement for the formation of additional vesicles.

Chaperone-assisted selective autophagy is a cellular process for the selective, ubiquitin-dependent degradation of chaperone-bound proteins in lysosomes.

Microautophagy is one of the three common forms of autophagic pathway, but unlike macroautophagy and chaperone-mediated autophagy, it is mediated—in mammals by lysosomal action or in plants and fungi by vacuolar action—by direct engulfment of the cytoplasmic cargo. Cytoplasmic material is trapped in the lysosome/vacuole by a random process of membrane invagination.

<span class="mw-page-title-main">QX39</span>

QX39 is a synthetic compound that activates chaperone-mediated autophagy (CMA) by increasing the expression of the lysosomal receptor for this pathway, LAMP2A lysosomes. It showed potent activity in vitro but has poor pharmacokinetic properties and was not suitable for animal research. Subsequent research led to the development of CA77.1, a CMA activator suitable for in vivo use.

<span class="mw-page-title-main">CA77.1</span>

CA77.1 (CA) is a synthetic compound that activates chaperone-mediated autophagy (CMA) by increasing the expression of the lysosomal receptor for this pathway, LAMP2A, in lysosomes. CA77.1 is a derivative of earlier compound AR7(HY-101106), which shows potent CMA activation in vitro but is not suitable for in vivo use. CA77.1 is able to activate CMA in vivo, and demonstrates brain penetrance and favorable pharmacokinetics. It has been shown in animal studies that in vivo administration of CA77.1 to enhance chaperone-mediated autophagy, may help to degrade toxic pathogenic protein products such as tau proteins and has potential applications in the treatment of Alzheimer's disease particularly in improving both behavior and neuropathology in PS19 mice models.

References

  1. 1 2 3 SCUDELLARI, MEGAN (1 November 2013). "Waste-Management Consultant". The Scientist Magazine®. Retrieved 27 July 2018.
  2. Aniento, F; Roche, E; Cuervo, AM; Knecht, E (15 May 1993). "Uptake and degradation of glyceraldehyde-3-phosphate dehydrogenase by rat liver lysosomes". The Journal of Biological Chemistry. 268 (14): 10463–70. doi: 10.1016/S0021-9258(18)82222-0 . PMID   8486700.
  3. Cuervo, A. M.; Dice, J. F. (1996-07-26). "A receptor for the selective uptake and degradation of proteins by lysosomes". Science. 273 (5274): 501–503. Bibcode:1996Sci...273..501C. doi:10.1126/science.273.5274.501. ISSN   0036-8075. PMID   8662539. S2CID   42850597.
  4. Cuervo, Ana Maria; Dice, J. Fred (6 October 2000). "Age-related Decline in Chaperone-mediated Autophagy". Journal of Biological Chemistry. 275 (40): 31505–31513. doi: 10.1074/jbc.M002102200 . ISSN   0021-9258. PMID   10806201.
  5. Bandyopadhyay, U; Sridhar, S; Kaushik, S; Kiffin, R; Cuervo, AM (27 August 2010). "Identification of regulators of chaperone-mediated autophagy". Molecular Cell. 39 (4): 535–47. doi:10.1016/j.molcel.2010.08.004. PMC   2945256 . PMID   20797626.
  6. Cuervo, AM; Stefanis, L; Fredenburg, R; Lansbury, PT; Sulzer, D (27 August 2004). "Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy". Science. 305 (5688): 1292–5. Bibcode:2004Sci...305.1292C. doi:10.1126/science.1101738. PMID   15333840. S2CID   84928456.
  7. Martinez-Vicente, M; Talloczy, Z; Wong, E; Tang, G; Koga, H; Kaushik, S; de Vries, R; Arias, E; Harris, S; Sulzer, D; Cuervo, AM (May 2010). "Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease". Nature Neuroscience. 13 (5): 567–76. doi:10.1038/nn.2528. PMC   2860687 . PMID   20383138.
  8. Orenstein, SJ; Kuo, SH; Tasset, I; Arias, E; Koga, H; Fernandez-Carasa, I; Cortes, E; Honig, LS; Dauer, W; Consiglio, A; Raya, A; Sulzer, D; Cuervo, AM (April 2013). "Interplay of LRRK2 with chaperone-mediated autophagy". Nature Neuroscience. 16 (4): 394–406. doi:10.1038/nn.3350. PMC   3609872 . PMID   23455607.
  9. "Ana Maria Cuervo, M.D., Ph.D., is Elected to the American Academy of Arts and Sciences". Albert Einstein College of Medicine. Archived from the original on 28 July 2018. Retrieved 28 July 2018.
  10. "Ana Maria Cuervo MD, PhD". The Michael J. Fox Foundation for Parkinson's Research. Retrieved 28 July 2018.
  11. "Ana Maria Cuervo, Ph.D, M.D". Einstein Experts for Media. Albert Einstein College of Medicine. Archived from the original on 28 July 2018. Retrieved 26 July 2018.
  12. "Ana Maria Cuervo, Ph.D., M.D. – Publications". einstein.pure.elsevier.com. Elsevier. Retrieved 28 July 2018.
  13. "Ana Maria Cuervo, M.D., Ph.D." www.einstein.yu.edu. Albert Einstein College of Medicine. Archived from the original on 3 March 2017. Retrieved 28 July 2018.
  14. "2019 NAS Election". www.nasonline.org. Retrieved 30 April 2019.